Skip to main content
. 2005 Jun;11(6):844–850. doi: 10.3201/eid1106.041146

Table 1. DNA oligonucleotides used in this study.

Primer/Probe Oligonucleotide sequence Final concentration (μmol)
mecA forward 5´ GGC AAT ATT ACC GCA CCT CA 3´ 0.30
mecA reverse 5´ GTC TGC CAC TTT CTC CTT GT 3´ 0.30
mecA probe 5´ FAM - AGA TCT TAT GCA AAC TTA ATT GGC AAA TCC - TAMRA 3´ 0.10
nuc forward 5´ CAA AGC ATC AAA AAG GTG TAG AGA 3´ 0.05
nuc reverse 5´ TTC AAT TTT CTT TGC ATT TTC TAC CA 3´ 0.05
nuc probe 5´ VIC - TTT TCG TAA ATG CAC TTG CTT CAG GAC CA - TAMRA 3´ 0.05
HHS Vulnerability Disclosure